Advanced Glycation End Products, Measured as Skin Autofluorescence and Diabetes Complications: A Systematic Review

Potential New Therapeutic Agents for Diabetic Kidney Disease

(2010) Faruk Turgut et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy

(2010) S. Chabroux et al.   DIABETES & METABOLISM

Reference Values of Skin Autofluorescence

(2010) M. Koetsier et al.   Diabetes Technology & Therapeutics

Epidemiology of Type 1 Diabetes

(2010) David M. Maahs et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus

(2009) H. L. Lutgers et al.   DIABETOLOGIA

The Role of Advanced Glycation End Products in Progression and Complications of Diabetes

(2008) Su-Yen Goh et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

AGEs, autofluorescence and renal function

(2008) E. G. Gerrits et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Skin autofluorescence in type 2 diabetes: Beyond blood glucose

(2007) Matteo Monami et al.   DIABETES RESEARCH AND CLINICAL PRACTICE